From cancer genomics to precision oncology--tissue's still an issue.
Cell
; 157(7): 1509-14, 2014 Jun 19.
Article
em En
| MEDLINE
| ID: mdl-24949964
ABSTRACT
Rapidly evolving genome technology has enabled extensive molecular analysis of limited tumor biopsy material, thereby facilitating the broader implementation of personalized cancer medicine. However, genomics-based patient stratification across diverse tumor types is unlikely to supplant tissue-of-origin considerations in addressing clinical needs, including the development and application of novel "rationally targeted" cancer therapies.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Medicina de Precisão
/
Neoplasias
Limite:
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article